Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
NCT04028492
Diabetic Gastroparesis, Digestive System Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00398801
The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology, natural history, clinical course, and other outcomes of gastroparesis.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
California Pacific Medical Center, San Francisco, California, United States
The Gastroparesis Registry (GpR) is an observational study to clarify the epidemiology, natural history, clinical course, and other outcomes of gastroparesis. The Gastroparesis Registry will also provide a resource to inform the development of clinical trials and ancillary studies of the epidemiology, etiology, pathophysiology, and impact of gastroparesis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Looking for future studies?
Notify MeJohns Hopkins Bloomberg School of Public Health
Other
Acronym: GpR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04028492
Diabetic Gastroparesis, Digestive System Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06401746
Digestive System Diseases, Gastrointestinal Diseases
Campbelltown, New South Wales, Australia
View Trial DetailsNCT06411574
Digestive System Diseases, Gastrointestinal Diseases
Campbelltown, New South Wales, Australia
View Trial DetailsNCT06646913
Connective Tissue Diseases, Digestive System Diseases
Ann Arbor, Michigan, United States
View Trial Details